News

Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been able to identify two biologically distinct types of multiple sclerosis (MS), in research led by UCL and Queen Square Analytics, a UCL spin out company.

PhD candidate Raafiah Mussa (UCL Queen Square Institute of Neurology) co-writes an article in The Conversation about the many challenges stroke survivors face and calls for increased ongoing NHS care and psychological support.

The UCLB pharmaceutical spinout, EpilepsyGTx which is developing new treatments for refractory epilepsy, has raised $33 million USD (£24.78 million) in Series A funding to bring its gene therapy to clinical trials.

UCL researchers have used advanced brain imaging to uncover the distinct brain changes between people with Parkinson’s disease and Lewy body dementia, opening the door to more targeted treatments

We're delighted that Dr Mena Farag (UCL Queen Square Institute of Neurology) was awarded the UK DRI PhD Prize on 9th December 2025 at Connectome 2025.

Professor Sarah Tabrizi (UCL Queen Square Institute of Neurology) has been named in Nature's 10 list, recognising the people involved in the most influential and important developments this year.